Sarcomas Completed Phase 2 Trials for Fondaparinux (DB00569)

Also known as: Sarcoma / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Soft tissue sarcoma

IndicationStatusPhase
DBCOND0041813 (Sarcomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00381888Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerTreatment